Financhill
Sell
40

LIN Quote, Financials, Valuation and Earnings

Last price:
$419.97
Seasonality move :
3.71%
Day range:
$418.27 - $425.34
52-week range:
$396.07 - $487.49
Dividend yield:
1.31%
P/E ratio:
32.22x
P/S ratio:
6.23x
P/B ratio:
5.16x
Volume:
6.6M
Avg. volume:
2.4M
1-year change:
4.42%
Market cap:
$202B
Revenue:
$32.9B
EPS (TTM):
$13.17
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $28.2B $27.2B $30.8B $33.4B $32.9B
Revenue Growth (YoY) 90.27% -3.49% 13.03% 8.35% -1.53%
 
Cost of Revenues $16.6B $15.4B $17.5B $19.5B $17.5B
Gross Profit $11.6B $11.9B $13.3B $13.9B $15.4B
Gross Profit Margin 41.04% 43.53% 43.03% 41.7% 46.76%
 
R&D Expenses $184M $152M $143M $143M $146M
Selling, General & Admin $3.5B $3.2B $3B $2.9B $3.1B
Other Inc / (Exp) -$303M -$390M -$299M -$1.1B -$81M
Operating Expenses $8.3B $8B $7.8B $7.2B $7.1B
Operating Income $3.3B $3.9B $5.5B $6.7B $8.3B
 
Net Interest Expenses $38M $115M $77M $63M $200M
EBT. Incl. Unusual Items $2.9B $3.4B $5.1B $5.5B $8B
Earnings of Discontinued Ops. $109M $4M $5M -- --
Income Tax Expense $769M $847M $1.3B $1.4B $1.8B
Net Income to Company $2.3B $2.5B $3.8B $4.1B $6.2B
 
Minority Interest in Earnings -$96M -$125M -$135M -$134M -$142M
Net Income to Common Excl Extra Items $2.3B $2.5B $3.8B $4.1B $6.2B
 
Basic EPS (Cont. Ops) $4.22 $4.75 $7.40 $8.30 $12.70
Diluted EPS (Cont. Ops) $4.19 $4.71 $7.33 $8.23 $12.59
Weighted Average Basic Share $541.1M $526.7M $516.9M $499.7M $488.2M
Weighted Average Diluted Share $545.2M $531.2M $521.9M $504M $492.3M
 
EBITDA $7.8B $8.3B $9.9B $10B $12.2B
EBIT $3.2B $3.6B $5.3B $5.8B $8.4B
 
Revenue (Reported) $28.2B $27.2B $30.8B $33.4B $32.9B
Operating Income (Reported) $3.3B $3.9B $5.5B $6.7B $8.3B
Operating Income (Adjusted) $3.2B $3.6B $5.3B $5.8B $8.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.9B $7.7B $8.8B $8.2B $8.4B
Revenue Growth (YoY) -2.07% 11.86% 14.72% -7.3% 2.47%
 
Cost of Revenues $3.8B $4.4B $5.3B $4.3B $4.4B
Gross Profit $3B $3.3B $3.5B $3.8B $4B
Gross Profit Margin 44.06% 43.04% 39.92% 47.1% 47.87%
 
R&D Expenses $36M $36M $35M $36M $37M
Selling, General & Admin $770M $793M $770M $808M $823M
Other Inc / (Exp) -$36M $29M $4M $49M -$49M
Operating Expenses $2B $2B $1.9B $1.8B $1.8B
Operating Income $1B $1.3B $1.7B $2B $2.2B
 
Net Interest Expenses $38M $8M $18M $40M $68M
EBT. Incl. Unusual Items $972M $1.3B $1.6B $2B $2.1B
Earnings of Discontinued Ops. $1M $1M -- -- --
Income Tax Expense $265M $321M $391M $487M $498M
Net Income to Company $642M $979M $1.3B $1.6B $1.6B
 
Minority Interest in Earnings -$31M -$31M -$27M -$36M -$53M
Net Income to Common Excl Extra Items $700M $979M $1.3B $1.6B $1.6B
 
Basic EPS (Cont. Ops) $1.33 $1.90 $2.56 $3.21 $3.24
Diluted EPS (Cont. Ops) $1.32 $1.88 $2.54 $3.19 $3.22
Weighted Average Basic Share $525.7M $515.2M $497.2M $487.1M $477.7M
Weighted Average Diluted Share $530.4M $520.1M $501.2M $491.1M $480.9M
 
EBITDA $2.2B $2.5B $2.7B $3B $3.1B
EBIT $1B $1.3B $1.7B $2.1B $2.1B
 
Revenue (Reported) $6.9B $7.7B $8.8B $8.2B $8.4B
Operating Income (Reported) $1B $1.3B $1.7B $2B $2.2B
Operating Income (Adjusted) $1B $1.3B $1.7B $2.1B $2.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $27.1B $29.8B $33.8B $32.5B $33B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $15.5B $16.7B $20B $17.5B $17.3B
Gross Profit $11.6B $13.1B $13.8B $15B $15.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $163M $143M $145M $143M $150M
Selling, General & Admin $3.2B $3.2B $2.9B $2.9B $3.1B
Other Inc / (Exp) -$469M -$161M -$1.1B -$231M -$137M
Operating Expenses $8B $8B $7.5B $6.9B $7.1B
Operating Income $3.6B $5B $6.3B $8.1B $8.7B
 
Net Interest Expenses $88M $81M $63M $160M $274M
EBT. Incl. Unusual Items $3B $4.8B $5.2B $7.7B $8.3B
Earnings of Discontinued Ops. $7M $4M $2M -- --
Income Tax Expense $756M $1.2B $1.4B $1.7B $1.9B
Net Income to Company $2.3B $3.6B $3.8B $6B $6.4B
 
Minority Interest in Earnings -$118M -$139M -$131M -$142M -$161M
Net Income to Common Excl Extra Items $2.2B $3.6B $3.8B $6B $6.4B
 
Basic EPS (Cont. Ops) $4.22 $6.86 $7.61 $12.20 $13.27
Diluted EPS (Cont. Ops) $4.21 $6.79 $7.56 $12.11 $13.17
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $7.9B $9.7B $9.7B $11.8B $12.6B
EBIT $3.3B $5B $5.3B $8B $8.8B
 
Revenue (Reported) $27.1B $29.8B $33.8B $32.5B $33B
Operating Income (Reported) $3.6B $5B $6.3B $8.1B $8.7B
Operating Income (Adjusted) $3.3B $5B $5.3B $8B $8.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $20B $22.5B $25.5B $24.6B $24.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $11.3B $12.6B $15B $13.1B $12.8B
Gross Profit $8.7B $9.9B $10.4B $11.5B $11.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $114M $105M $107M $107M $111M
Selling, General & Admin $2.4B $2.4B $2.3B $2.4B $2.4B
Other Inc / (Exp) -$311M -$82M -$883M -$23M $11M
Operating Expenses $5.9B $6B $5.7B $5.3B $5.4B
Operating Income $2.7B $3.9B $4.7B $6.1B $6.5B
 
Net Interest Expenses $80M $46M $32M $129M $203M
EBT. Incl. Unusual Items $2.3B $3.7B $3.8B $6B $6.3B
Earnings of Discontinued Ops. $3M $3M -- -- --
Income Tax Expense $594M $923M $1B $1.4B $1.5B
Net Income to Company $1.7B $2.8B $2.8B $4.7B $4.8B
 
Minority Interest in Earnings -$91M -$105M -$101M -$109M -$128M
Net Income to Common Excl Extra Items $1.7B $2.8B $2.8B $4.7B $4.8B
 
Basic EPS (Cont. Ops) $3.27 $5.39 $5.61 $9.51 $10.08
Diluted EPS (Cont. Ops) $3.26 $5.34 $5.58 $9.44 $10.01
Weighted Average Basic Share $1.6B $1.6B $1.5B $1.5B $1.4B
Weighted Average Diluted Share $1.6B $1.6B $1.5B $1.5B $1.4B
 
EBITDA $5.9B $7.3B $7.1B $9B $9.4B
EBIT $2.4B $3.8B $3.9B $6.1B $6.5B
 
Revenue (Reported) $20B $22.5B $25.5B $24.6B $24.7B
Operating Income (Reported) $2.7B $3.9B $4.7B $6.1B $6.5B
Operating Income (Adjusted) $2.4B $3.8B $3.9B $6.1B $6.5B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2.7B $3.8B $2.8B $5.4B $4.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.3B $4.2B $4.5B $4.6B $4.7B
Inventory $1.7B $1.7B $1.7B $2B $2.1B
Prepaid Expenses $516M $516M $527M $597M $583M
Other Current Assets $264M $221M $146M $104M $93M
Total Current Assets $10.4B $10.9B $10.2B $13B $12.6B
 
Property Plant And Equipment $30.1B $29.8B $27B $24.4B $25.5B
Long-Term Investments $2.1B $2.1B $2.6B $2.5B $2.4B
Goodwill $27B $28.2B $27B $25.8B $26.8B
Other Intangibles $16.1B $16.2B $13.8B $12.4B $12.4B
Other Long-Term Assets $249M $278M $324M $243M $261M
Total Assets $86.6B $88.2B $81.6B $79.7B $80.8B
 
Accounts Payable $3.3B $3.1B $3.5B $3B $3B
Accrued Expenses $2B $2.2B $2.1B $2.3B $2.3B
Current Portion Of Long-Term Debt $1.5B $751M $1.7B $1.6B $1.3B
Current Portion Of Capital Lease Obligations $260M $275M $262M $223M $227M
Other Current Liabilities $945M $1.2B $1.2B $1.3B $1.3B
Total Current Liabilities $12.2B $13.7B $13.6B $16.5B $15.7B
 
Long-Term Debt $10.7B $12.2B $11.3B $12.2B $13.4B
Capital Leases -- -- -- -- --
Total Liabilities $35B $38.6B $36.2B $38.3B $39.7B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$4.8B -$4.7B -$5B -$5.8B -$5.8B
Common Equity $49.1B $47.3B $44B $40B $39.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.6B $2.3B $1.4B $1.4B $1.4B
Total Equity $51.6B $49.6B $45.4B $41.4B $41.1B
 
Total Liabilities and Equity $86.6B $88.2B $81.6B $79.7B $80.8B
Cash and Short Terms $2.7B $3.8B $2.8B $5.4B $4.7B
Total Debt $14B $16.2B $14.2B $17.9B $19.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $5.2B $4.7B $3.8B $3.9B $5.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.5B $4.4B $4.6B $4.7B $4.9B
Inventory $1.7B $1.7B $1.9B $2.1B $2.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $1.1B $889M $922M $1.1B
Total Current Assets $12.3B $12B $11.2B $11.7B $13.5B
 
Property Plant And Equipment $27.9B $26.2B $22.6B $23.6B $25.1B
Long-Term Investments -- -- -- -- --
Goodwill $27.2B $27.2B $24.6B $26B $27.1B
Other Intangibles $15.7B $14B $11.8B $12.1B $12.1B
Other Long-Term Assets $4B $4.8B $4.2B $4.4B $4.7B
Total Assets $87.2B $84.2B $74.3B $77.8B $82.5B
 
Accounts Payable $2.9B $3.1B $3.1B $2.8B $2.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $1.8B $2.3B $1.6B $922M $1.3B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $4.3B $4.3B $4.4B $4.7B $4.7B
Total Current Liabilities $14.8B $14.8B $15.1B $14.2B $14B
 
Long-Term Debt $12B $11.5B $10.6B $13.2B $17.5B
Capital Leases -- -- -- -- --
Total Liabilities $38.6B $38.5B $35.4B $37.6B $41.9B
 
Common Stock $1M $1M $1M -- $1M
Other Common Equity Adj -$6B -$5.6B -$8.1B -$6.7B -$6.1B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.4B $1.4B $1.3B $1.3B $1.4B
Total Equity $48.6B $45.7B $38.9B $40.2B $40.6B
 
Total Liabilities and Equity $87.2B $84.2B $74.3B $77.8B $82.5B
Cash and Short Terms $5.2B $4.7B $3.8B $3.9B $5.2B
Total Debt $17.8B $16.7B $15.3B $18B $22.3B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.3B $2.5B $3.8B $4.1B $6.2B
Depreciation & Amoritzation $4.7B $4.6B $4.6B $4.2B $3.8B
Stock-Based Compensation $95M $133M $128M $107M $141M
Change in Accounts Receivable $80M $19M -$553M -$423M -$86M
Change in Inventories -$81M $18M -$129M -$347M -$127M
Cash From Operations $6.2B $7.4B $9.7B $8.9B $9.3B
 
Capital Expenditures $3.7B $3.4B $3.1B $3.2B $3.8B
Cash Acquisitions $4.9B $414M $79M $85M -$883M
Cash From Investing $1.1B -$3B -$3B -$3.1B -$4.7B
 
Dividends Paid (Ex Special Dividend) -$1.9B -$2B -$2.2B -$2.3B -$2.5B
Special Dividend Paid
Long-Term Debt Issued $99M $2.8B $2.3B $3.2B $2.2B
Long-Term Debt Repaid -$1.6B -$2.7B -$1.5B -$1.8B -$1.7B
Repurchase of Common Stock -$2.7B -$2.5B -$4.6B -$5.2B -$4B
Other Financing Activities -$3.3B -$220M -$323M -$88M -$53M
Cash From Financing -$9B -$3.3B -$7.6B -$3.1B -$5.4B
 
Beginning Cash (CF) $4.5B $2.7B $3.8B $2.8B $5.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.7B $1.1B -$870M $2.7B -$765M
Ending Cash (CF) $2.7B $3.8B $2.8B $5.4B $4.7B
 
Levered Free Cash Flow $2.5B $4B $6.6B $5.7B $5.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $642M $979M $1.3B $1.6B $1.6B
Depreciation & Amoritzation $1.2B $1.2B $1B $959M $960M
Stock-Based Compensation $29M $32M $27M $36M $42M
Change in Accounts Receivable $42M -$151M -$29M $6M $224M
Change in Inventories -$19M -$35M -$156M -$40M $55M
Cash From Operations $1.9B $2.6B $2.6B $2.5B $2.7B
 
Capital Expenditures $787M $741M $762M $948M $1.1B
Cash Acquisitions $55M $70M $62M $2M $109M
Cash From Investing -$732M -$671M -$700M -$946M -$957M
 
Dividends Paid (Ex Special Dividend) -$506M -$546M -$581M -$620M -$662M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.1B $2.2B -- $8M $8M
Long-Term Debt Repaid -$1.5B -$3M -$22M -$10M -$16M
Repurchase of Common Stock -$202M -$1.2B -$1.1B -$1.2B -$667M
Other Financing Activities -$53M -$42M -$27M -$59M -$44M
Cash From Financing -$933M -$256M -$1.7B -$964M -$1.3B
 
Beginning Cash (CF) $4.9B $3.1B $3.7B $3.4B $4.6B
Foreign Exchange Rate Adjustment $39M -$66M -$115M -$73M $60M
Additions / Reductions $219M $1.6B $216M $610M $501M
Ending Cash (CF) $5.2B $4.7B $3.8B $3.9B $5.2B
 
Levered Free Cash Flow $1.1B $1.8B $1.9B $1.6B $1.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.3B $3.6B $3.8B $6B $6.4B
Depreciation & Amoritzation $4.6B $4.7B $4.4B $3.8B $3.8B
Stock-Based Compensation $135M $124M $111M $131M $159M
Change in Accounts Receivable $34M -$444M -$586M -$20M -$115M
Change in Inventories -$121M $42M -$352M -$172M $30M
Cash From Operations $7.2B $8.9B $10B $8.7B $9.3B
 
Capital Expenditures $3.4B $3.3B $3.1B $3.6B $4.4B
Cash Acquisitions $466M $136M -$7M -$753M -$96M
Cash From Investing -$2.9B -$3.1B -$3.1B -$4.3B -$4.5B
 
Dividends Paid (Ex Special Dividend) -$2B -$2.2B -$2.3B -$2.5B -$2.6B
Special Dividend Paid
Long-Term Debt Issued $2.8B $2.3B $2.3B $3B $4.9B
Long-Term Debt Repaid -$1.6B -$1.9B -$2.4B -$1.7B -$1B
Repurchase of Common Stock -$2.8B -$3.7B -$5.8B -$3.6B -$4.2B
Other Financing Activities -$204M -$338M -$66M -$107M -$233M
Cash From Financing -$1.1B -$6.3B -$7.7B -$4.2B -$3.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.2B -$550M -$777M $118M $1.3B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $3.8B $5.7B $6.9B $5.1B $4.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.7B $2.8B $2.8B $4.7B $4.8B
Depreciation & Amoritzation $3.4B $3.5B $3.2B $2.9B $2.9B
Stock-Based Compensation $104M $95M $78M $102M $120M
Change in Accounts Receivable -$76M -$539M -$572M -$169M -$198M
Change in Inventories -$101M -$77M -$300M -$125M $32M
Cash From Operations $5B $6.5B $6.8B $6.6B $6.6B
 
Capital Expenditures $2.4B $2.2B $2.2B $2.6B $3.2B
Cash Acquisitions $394M $116M $30M -$808M -$21M
Cash From Investing -$2B -$2.1B -$2.2B -$3.4B -$3.3B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.6B -$1.8B -$1.9B -$2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.8B $2.3B $2.3B $2.1B $4.8B
Long-Term Debt Repaid -$1.6B -$821M -$1.7B -$1.7B -$973M
Repurchase of Common Stock -$2B -$3.3B -$4.5B -$2.9B -$3.1B
Other Financing Activities -$201M -$319M -$62M -$81M -$261M
Cash From Financing -$378M -$3.4B -$3.5B -$4.6B -$2.7B
 
Beginning Cash (CF) $11.7B $11B $10.9B $13.8B $14.1B
Foreign Exchange Rate Adjustment -$139M -$44M -$150M -$56M -$74M
Additions / Reductions $2.6B $990M $1.1B -$1.5B $597M
Ending Cash (CF) $14.2B $11.9B $11.9B $12.2B $14.7B
 
Levered Free Cash Flow $2.6B $4.2B $4.5B $3.9B $3.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 0.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.88% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.35% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock